Literature DB >> 6787085

Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis.

J P Pandey, J M Goust, J P Salier, H H Fudenberg.   

Abstract

Serum samples from 70 Caucasian patients with multiple sclerosis were typed for nine Gm markers. Significant association was found with the Gm 1,17;21 phenotype, and the relative risk for individuals with this phenotype was calculated at 3.6. The data indicate that Caucasians positive for Gm 1,17;21 are almost four times more likely to develop multiple sclerosis than those without this phenotype.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6787085      PMCID： PMC370759          DOI： 10.1172/jci110220

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


  29 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

2.  HLA studies on multiple sclerosis in Japan.

Authors:  S Saito; S Naito; S Kawanami; Y Kurowa
Journal:  Neurology       Date:  1976-06       Impact factor: 9.910

Review 3.  Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis.

Authors:  W W Tourtellotte; B I Ma
Journal:  Neurology       Date:  1978-09       Impact factor: 9.910

Review 4.  Functional specificity of thymus- dependent lymphocytes.

Authors:  W E Paul; B Benacerraf
Journal:  Science       Date:  1977-03-25       Impact factor: 47.728

5.  A new rapid method for genetic typing of human immunoglobulins.

Authors:  G N Vyas; H H Fudenberg; H M Pretty; E R Gold
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

6.  RElation of the human antibody response to flagellin to GM genotype.

Authors:  J V Wells; H H Fudenberg; I R MacKay
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

7.  IgG subclasses, barrier function for albumin and production of immunoglobulin G in the central nervous system.

Authors:  S Al-Kassab; L Dittmann; H Olesen
Journal:  Acta Neurol Scand       Date:  1979-09       Impact factor: 3.209

8.  HLA antigens in black American patients with multiple sclerosis.

Authors:  B Dupont; R P Lisak; C Jersild; J A Hansen; D H Silberberg; C Whitsett; B Zweiman; K Ciongoli
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

9.  Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis.

Authors:  E Norrby; H Link; J E Olsson; M Panelius; A Salmi; B Vandvik
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

10.  Linkage between the frequency of muscular weakness and loci that regulate immune responsiveness in murine experimental myasthenia gravis.

Authors:  P W Berman; J Patrick
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307
View more
  15 in total

Review 1.  Gm allotype system and autoimmune diseases.

Authors:  M Abu-Shakra; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Class II HLA antigens in multiple sclerosis.

Authors:  D H Miller; R W Hornabrook; J Dagger; R Fong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

3.  Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism.

Authors:  C N Gaiser; M J Johnson; G de Lange; L Rassenti; L L Cavalli-Sforza; L Steinman
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

4.  Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment.

Authors:  E Mignot; C Wang; C Rattazzi; C Gaiser; M Lovett; C Guilleminault; W C Dement; F C Grumet
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Susceptibility to multiple sclerosis is associated with the proximal immunoglobulin heavy chain variable region.

Authors:  M A Walter; W T Gibson; G C Ebers; D W Cox
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Susceptibility to multiple sclerosis and the immunoglobulin heavy chain variable region.

Authors:  N W Wood; S J Sawcer; H F Kellar-Wood; P Holmans; D Clayton; N Robertson; D A Compston
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

7.  Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis.

Authors:  Dorothea Buck; Eva Albrecht; Muhammad Aslam; An Goris; Natalie Hauenstein; Angela Jochim; Sabine Cepok; Verena Grummel; Bénédicte Dubois; Achim Berthele; Peter Lichtner; Christian Gieger; Juliane Winkelmann; Bernhard Hemmer
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

8.  Distribution of nominal and latent IgG (Gm) allotypes in plaques of multiple sclerosis brain.

Authors:  J P Salier; P Glynn; J M Goust; M L Cuzner
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

9.  Do antibodies to myelin basic protein isolated from multiple sclerosis cross-react with measles and other common virus antigens?

Authors:  C C Bernard; E Townsend; V B Randell; H G Williamson
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

10.  Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.

Authors:  J P Salier; R Sesboüé; C Martin-Mondière; M Daveau; P Cesaro; B Cavelier; A Coquerel; L Legrand; J M Goust; J D Degos
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.